AGM/EGMJul 29, 2026, 04:33 PM
Biodexa Shareholders Approve Share Reorganization, ADS Ratio Change
AI Summary
Biodexa Pharmaceuticals Plc announced that all four resolutions proposed at its General Meeting were duly passed. This includes a share reorganization that reduces the number of outstanding ordinary shares by a factor of 10,000 and changes the ordinary share per ADS ratio from 500,000:1 to 50:1, effective July 30, 2026. The company clarified that these changes do not constitute a reverse split and will not alter the proportional ownership of shareholders or ADS holders. Additionally, directors were granted authority to allot ordinary shares on a non-pre-emptive basis.
Key Highlights
- All four resolutions put to shareholders at the General Meeting were passed.
- Outstanding ordinary shares reduced by a factor of 10,000.
- Nominal value of £0.000001 per ordinary share remains unchanged.
- Ordinary share per ADS ratio changed from 500,000:1 to 50:1.
- Changes effective July 30, 2026; proportional ownership remains unchanged.
- Post-reorganization: 51,453,281 ordinary shares and 1,029,063 ADSs outstanding.
- Directors granted authority to allot ordinary shares on a non-pre-emptive basis.
Price Impact
More from BDRX